Re: The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy

BJU Int. 2008 Jan;101(1):127. doi: 10.1111/j.1464-410X.2007.07380_1.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Intravesical
  • Antineoplastic Agents / adverse effects*
  • Combined Modality Therapy
  • Cystectomy / mortality
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Drug Resistance, Neoplasm
  • Epirubicin / adverse effects*
  • Gemcitabine
  • Humans
  • Urinary Bladder Neoplasms / mortality*
  • Urinary Bladder Neoplasms / therapy

Substances

  • Antineoplastic Agents
  • Deoxycytidine
  • Epirubicin
  • Gemcitabine